Free Trial
→ June 12 is 9 days away. Move now. (From Behind the Markets) (Ad)tc pixel Free G Stock Alerts

Genpact (G) Financials

Genpact logo
$31.25 +0.25 (+0.80%)
As of 02:32 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Genpact

Annual Income Statements for Genpact

This table shows Genpact's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 240 270 263 564 305 308 369 353 631 514 552
Consolidated Net Income / (Loss)		 240 268 261 563 305 308 369 353 631 514 552
Net Income / (Loss) Continuing Operations		 240 268 261 281 305 308 369 353 631 514 552
Total Pre-Tax Income 		302 330 321 362 399 400 483 465 602 677 730
Total Operating Income		 334 341 331 348 429 439 509 502 631 702 750
Total Gross Profit		 967 1,016 1,055 1,079 1,226 1,291 1,432 1,536 1,571 1,690 1,831
Total Revenue		 2,461 2,571 2,737 3,001 3,521 3,709 4,022 4,371 4,477 4,767 5,080
Operating Revenue		 2,461 2,571 2,737 3,001 3,521 3,709 4,022 4,371 4,477 4,767 5,080
Total Cost of Revenue		 1,494 1,554 1,681 1,922 2,295 2,418 2,590 2,835 2,906 3,077 3,249
Operating Cost of Revenue		 1,494 1,554 1,681 1,922 2,295 2,418 2,590 2,835 2,906 3,077 3,249
Total Operating Expenses		 633 675 724 731 796 853 923 1,034 940 988 1,081
Selling, General & Admin Expense		 608 653 689 694 795 790 866 938 913 967 1,047
Amortization Expense		 29 27 36 39 33 43 58 43 31 26 24
Other Operating Expenses / (Income)		 -3.32 -4.94 -1.66 -1.85 -31 19 -1.20 53 -4.72 -5.62 9.80
Total Other Income / (Expense), net		 -32 -12 -11 14 -30 -38 -26 -37 -29 -25 -20
Interest & Investment Income		 -42 -24 -36 -37 -43 -49 -51 -52 -48 -47 -50
Other Income / (Expense), net		 9.63 12 26 51 14 11 26 15 19 22 30
Income Tax Expense		 62 62 60 81 95 92 114 112 -29 163 178
Basic Earnings per Share		 $1.11 $1.30 $1.36 $1.48 $1.60 $1.62 $1.97 $1.92 $3.46 $2.88 $3.18
Weighted Average Basic Shares Outstanding		 216.61M 206.86M 193.86M 190.67M 190.07M 190.40M 187.80M 184.18M 182.35M 178.39M 173.89M
Diluted Earnings per Share		 $1.09 $1.28 $1.34 $1.45 $1.56 $1.57 $1.91 $1.88 $3.41 $2.85 $3.13
Weighted Average Diluted Shares Outstanding		 219.15M 210.13M 197.05M 193.98M 195.16M 195.78M 192.96M 188.09M 185.14M 180.44M 176.65M
Weighted Average Basic & Diluted Shares Outstanding		 216.10M 207.40M 193.50M 190.60M 190.40M 188.14M 185.17M 183.98M 180.73M 175.67M 169.86M
Cash Dividends to Common per Share		 - $0.00 $0.24 $0.30 $0.34 $0.39 $0.11 $0.13 $0.55 $0.61 $0.68

Quarterly Income Statements for Genpact

This table shows Genpact's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 118 291 117 122 133 142 131 133 146 143 148
Consolidated Net Income / (Loss)		 118 291 117 122 133 142 131 133 146 143 148
Net Income / (Loss) Continuing Operations		 118 291 117 122 133 142 131 133 146 143 148
Total Pre-Tax Income 		155 158 156 162 175 183 175 177 189 189 194
Total Operating Income		 166 163 160 170 182 190 184 179 192 195 199
Total Gross Profit		 403 408 396 416 431 446 429 450 470 482 472
Total Revenue		 1,136 1,146 1,131 1,176 1,211 1,249 1,215 1,254 1,291 1,319 1,296
Operating Revenue		 1,136 1,146 1,131 1,176 1,211 1,249 1,215 1,254 1,291 1,319 1,296
Total Cost of Revenue		 733 739 735 760 780 803 786 804 822 837 824
Operating Cost of Revenue		 733 739 735 760 780 803 786 804 822 837 824
Total Operating Expenses		 237 245 236 246 250 256 245 271 278 287 273
Selling, General & Admin Expense		 230 237 235 240 243 249 241 266 262 277 270
Amortization Expense		 7.50 7.45 6.93 6.56 6.50 6.50 4.32 4.32 8.29 7.37 3.11
Other Operating Expenses / (Income)		 -0.09 -0.05 -5.47 -0.07 -0.02 -0.06 -0.11 -0.04 7.62 2.33 -0.36
Total Other Income / (Expense), net		 -11 -4.26 -3.62 -7.83 -6.16 -7.63 -8.48 -2.66 -2.29 -6.63 -4.59
Interest & Investment Income		 -13 -13 -10 -14 -12 -11 -11 -13 -13 -12 -12
Other Income / (Expense), net		 2.47 8.66 6.62 5.70 6.22 3.42 2.97 11 10 5.25 7.01
Income Tax Expense		 37 -133 39 40 43 41 44 44 44 46 46
Basic Earnings per Share		 $0.65 $1.60 $0.65 $0.68 $0.75 $0.80 $0.75 $0.76 $0.84 $0.83 $0.87
Weighted Average Basic Shares Outstanding		 181.40M 182.35M 180.42M 179.65M 177.60M 178.39M 175.53M 174.61M 173.58M 173.89M 170.31M
Diluted Earnings per Share		 $0.64 $1.57 $0.64 $0.67 $0.74 $0.80 $0.73 $0.75 $0.83 $0.82 $0.86
Weighted Average Diluted Shares Outstanding		 183.80M 185.14M 181.94M 180.91M 179.71M 180.44M 178.44M 177.05M 176.10M 176.65M 172.85M
Weighted Average Basic & Diluted Shares Outstanding		 181.41M 180.73M 179.98M 178.18M 176.36M 175.67M 174.87M 174.27M 172.41M 169.86M 169.51M
Cash Dividends to Common per Share		 $0.14 - $0.15 $0.15 $0.15 - $0.17 $0.17 $0.17 - $0.19

Annual Cash Flow Statements for Genpact

This table details how cash moves in and out of Genpact's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 8.08 -13 44 -72 110 226 239 -164 -71 85 211
Net Cash From Operating Activities		 327 346 359 340 428 584 694 444 491 615 813
Net Cash From Continuing Operating Activities		 327 346 359 341 428 584 694 444 491 615 813
Net Income / (Loss) Continuing Operations		 240 268 261 283 305 308 369 353 631 514 552
Consolidated Net Income / (Loss)		 240 268 261 281 305 308 369 353 631 514 552
Depreciation Expense		 54 55 59 65 96 116 109 87 73 70 71
Amortization Expense		 42 29 38 43 34 46 61 45 33 29 27
Non-Cash Adjustments To Reconcile Net Income		 37 -15 9.64 -17 -14 20 160 138 55 -6.86 -44
Changes in Operating Assets and Liabilities, net		 -46 10 -8.20 -33 6.25 94 -5.54 -180 -301 9.94 207
Net Cash From Investing Activities		 -100 -126 -362 -276 -357 -266 -123 -37 -79 -106 -495
Net Cash From Continuing Investing Activities		 -100 -126 -362 -276 -357 -266 -123 -37 -79 -106 -495
Purchase of Property, Plant & Equipment		 -62 -82 -57 -85 -75 -70 -53 -51 -55 -83 -78
Acquisitions		 -40 -62 -306 -187 -34 -197 -76 -3.81 -4.04 -2.47 -91
Purchase of Investments		 - - - - - - - 0.00 0.00 -23 -350
Sale of Property, Plant & Equipment		 1.49 0.55 1.74 0.67 1.75 0.61 6.38 0.06 0.03 2.64 0.06
Divestitures		 - 17 - 0.00 -250 0.00 0.14 18 -20 0.00 0.00
Sale and/or Maturity of Investments		 - - - - - - - - 0.00 0.00 23
Net Cash From Financing Activities		 -219 -233 47 -135 40 -92 -333 -571 -483 -425 -107
Net Cash From Continuing Financing Activities		 -219 -233 47 -135 40 -92 -333 -571 -483 -425 -107
Repayment of Debt		 -2,258 -103 -328 -295 -661 -475 -301 -746 -321 -509 -125
Repurchase of Preferred Equity		 - - -0.02 - - - - - -225 -253 -283
Payment of Dividends		 - - -47 -57 -65 -74 -80 -92 -100 -108 -118
Issuance of Debt		 2,252 200 645 379 800 610 350 500 148 450 435
Issuance of Common Equity		 16 18 16 14 20 25 35 28 39 17 18
Other Financing Activities, net		 -0.86 -2.25 -19 -22 -24 -41 -38 -47 -24 -22 -33
Cash Interest Paid		 21 20 28 41 45 49 46 51 48 69 60
Cash Income Taxes Paid		 72 47 66 81 104 194 32 146 157 114 144

Quarterly Cash Flow Statements for Genpact

This table details how cash moves in and out of Genpact's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 67 28 -98 440 98 -355 -84 91 80 124 -259
Net Cash From Operating Activities		 162 192 -26 209 228 203 40 177 308 287 -24
Net Cash From Continuing Operating Activities		 162 192 -26 209 228 203 40 177 308 287 -24
Net Income / (Loss) Continuing Operations		 118 291 117 122 133 142 131 133 146 143 148
Consolidated Net Income / (Loss)		 118 291 117 122 133 142 131 133 146 143 148
Depreciation Expense		 18 18 17 17 17 18 17 17 18 19 18
Amortization Expense		 7.99 7.95 7.42 7.11 7.21 7.16 4.87 4.87 8.85 8.04 3.88
Non-Cash Adjustments To Reconcile Net Income		 -23 92 -8.95 19 36 -53 6.56 -13 29 -68 -22
Changes in Operating Assets and Liabilities, net		 42 -218 -158 44 35 89 -119 35 106 184 -171
Net Cash From Investing Activities		 -14 -19 -25 -20 -20 -41 0.78 -105 -19 -372 -31
Net Cash From Continuing Investing Activities		 -14 -19 -25 -20 -20 -41 0.78 -105 -19 -372 -31
Purchase of Property, Plant & Equipment		 -13 -18 -24 -19 -20 -20 -22 -22 -16 -18 -24
Acquisitions		 -0.86 19 -0.67 -0.59 -0.53 -0.68 -0.60 -83 -2.90 -4.20 -7.52
Sale and/or Maturity of Investments		 - - 0.00 - - - 23 - - - 0.00
Net Cash From Financing Activities		 -81 -145 -48 251 -110 -517 -126 19 -209 209 -204
Net Cash From Continuing Financing Activities		 -81 -145 -48 251 -110 -517 -126 19 -209 209 -204
Repayment of Debt		 -57 -48 -27 -62 -10 -410 -8.97 -8.76 -94 -14 -9.44
Repurchase of Preferred Equity		 - - -30 -63 -75 - -63 -30 -90 -100 -70
Payment of Dividends		 -25 -25 -27 -27 -27 -27 -30 -30 -29 -29 -32
Issuance of Common Equity		 2.71 4.85 6.80 2.92 2.45 5.05 6.94 2.40 5.00 3.16 2.82
Other Financing Activities, net		 -1.37 -1.84 -21 -0.32 -0.17 -0.97 -31 -0.13 -0.96 -1.55 -96
Cash Interest Paid		 9.00 16 11 19 8.56 30 7.15 23 7.78 22 6.62
Cash Income Taxes Paid		 57 33 20 26 32 36 21 31 47 45 40

Annual Balance Sheets for Genpact

This table presents Genpact's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 2,793 2,886 3,450 3,529 4,454 4,874 4,975 4,589 4,806 4,987 5,843
Total Current Assets		 1,195 1,227 1,434 1,355 1,552 1,749 1,922 1,779 1,892 2,080 2,656
Cash & Equivalents		 451 423 504 368 467 680 899 647 584 648 854
Short-Term Investments		 - - - - - - - - 0.00 23 350
Accounts Receivable		 590 615 693 774 914 881 888 995 1,116 1,199 1,241
Prepaid Expenses		 154 189 236 212 170 187 134 138 192 210 212
Plant, Property, & Equipment, net		 175 193 207 213 254 231 215 181 190 208 190
Total Noncurrent Assets		 1,423 1,466 1,809 1,962 2,648 2,894 2,839 2,629 2,724 2,699 2,996
Goodwill		 1,038 1,069 1,337 1,394 1,574 1,696 1,731 1,684 1,684 1,670 1,781
Intangible Assets		 99 79 132 177 231 237 170 90 53 27 67
Noncurrent Deferred & Refundable Income Taxes		 99 70 77 75 90 107 106 135 299 269 259
Other Noncurrent Operating Assets		 180 242 262 315 753 854 832 719 689 733 890
Total Liabilities & Shareholders' Equity		 2,793 2,886 3,450 3,529 4,454 4,874 4,975 4,589 4,806 4,987 5,843
Total Liabilities		 1,489 1,595 2,021 2,125 2,765 3,039 3,078 2,763 2,557 2,598 3,294
Total Current Liabilities		 594 731 839 976 910 1,203 1,309 1,103 1,318 964 1,602
Short-Term Debt		 61 199 209 328 104 284 383 177 442 26 376
Accounts Payable		 10 9.77 15 43 22 14 25 36 28 36 28
Current Deferred & Payable Income Tax Liabilities		 24 24 30 34 43 42 47 45 38 35 43
Other Current Liabilities		 500 498 584 571 742 863 853 845 809 866 1,156
Total Noncurrent Liabilities		 895 863 1,182 1,149 1,855 1,837 1,769 1,659 1,239 1,634 1,691
Long-Term Debt		 737 698 1,007 976 1,340 1,307 1,272 1,249 825 1,195 1,166
Noncurrent Deferred & Payable Income Tax Liabilities		 2.09 2.42 6.75 8.08 3.99 1.52 3.94 4.18 12 16 21
Other Noncurrent Operating Liabilities		 155 163 169 165 511 528 493 406 403 423 504
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,304 1,287 1,424 1,404 1,689 1,834 1,897 1,826 2,248 2,390 2,549
Total Preferred & Common Equity		 1,304 1,287 1,424 1,404 1,689 1,834 1,897 1,826 2,248 2,390 2,549
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 1,304 1,287 1,424 1,404 1,689 1,834 1,897 1,826 2,248 2,390 2,549
Common Stock		 1,344 1,386 1,423 1,473 1,572 1,638 1,719 1,779 1,886 1,947 2,021
Retained Earnings		 412 358 356 438 649 742 732 780 1,085 1,237 1,390
Accumulated Other Comprehensive Income / (Loss)		 -451 -458 -355 -507 -532 -545 -554 -733 -723 -794 -861

Quarterly Balance Sheets for Genpact

This table presents Genpact's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 4,537 4,506 4,482 4,599 4,741 5,178 5,326 4,895 5,308 5,364 5,617
Total Current Assets		 1,758 1,734 1,748 1,870 1,830 2,266 2,401 1,943 2,135 2,212 2,405
Cash & Equivalents		 519 552 491 541 478 914 1,023 562 663 741 578
Short-Term Investments		 - - - - - - - 0.00 0.00 0.00 350
Accounts Receivable		 994 1,005 1,008 1,054 1,147 1,160 1,214 1,192 1,267 1,281 1,260
Prepaid Expenses		 230 176 249 274 205 192 164 189 205 191 217
Plant, Property, & Equipment, net		 180 179 180 180 194 200 208 211 219 181 181
Total Noncurrent Assets		 2,598 2,593 2,554 2,550 2,716 2,713 2,717 2,741 2,953 2,971 3,031
Goodwill		 1,681 1,687 1,685 1,678 1,680 1,678 1,683 1,673 1,794 1,784 1,768
Intangible Assets		 101 80 71 62 46 40 33 23 77 71 70
Noncurrent Deferred & Refundable Income Taxes		 112 131 131 138 282 277 289 258 244 254 269
Other Noncurrent Operating Assets		 704 695 667 672 708 718 712 788 838 862 925
Total Liabilities & Shareholders' Equity		 4,537 4,506 4,482 4,599 4,741 5,178 5,326 4,895 5,308 5,364 5,617
Total Liabilities		 2,805 2,581 2,549 2,589 2,442 2,841 2,931 2,442 2,721 2,820 3,142
Total Current Liabilities		 1,633 945 931 979 1,185 1,198 1,295 792 1,392 1,462 1,426
Short-Term Debt		 735 206 129 81 476 426 426 26 461 376 376
Accounts Payable		 28 23 42 27 28 28 19 37 44 35 26
Current Deferred & Payable Income Tax Liabilities		 107 64 94 131 39 44 53 40 56 54 43
Other Current Liabilities		 754 652 667 740 642 700 797 688 832 997 981
Total Noncurrent Liabilities		 1,172 1,636 1,618 1,610 1,257 1,643 1,636 1,650 1,329 1,358 1,716
Long-Term Debt		 747 1,243 1,237 1,230 818 1,208 1,201 1,189 833 827 1,160
Noncurrent Deferred & Payable Income Tax Liabilities		 3.63 4.49 3.79 3.82 12 10 12 16 17 16 21
Other Noncurrent Operating Liabilities		 421 389 378 376 427 425 423 445 478 514 534
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,732 1,925 1,933 2,009 2,298 2,338 2,395 2,453 2,587 2,545 2,475
Total Preferred & Common Equity		 1,732 1,925 1,933 2,009 2,298 2,338 2,395 2,453 2,587 2,545 2,475
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 1,732 1,925 1,933 2,009 2,298 2,338 2,395 2,453 2,587 2,545 2,475
Common Stock		 1,742 1,797 1,833 1,858 1,881 1,902 1,924 1,943 1,967 1,993 2,023
Retained Earnings		 745 831 801 894 1,145 1,176 1,207 1,275 1,347 1,374 1,436
Accumulated Other Comprehensive Income / (Loss)		 -755 -702 -701 -742 -727 -740 -736 -765 -727 -822 -984

Annual Metrics And Ratios for Genpact

This table displays calculated financial ratios and metrics derived from Genpact's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 7.97% 4.46% 6.46% 9.64% 17.32% 5.36% 8.43% 8.68% 2.42% 6.48% 6.56%
EBITDA Growth		 20.06% -0.77% 3.86% 11.72% 13.13% 6.65% 15.25% -7.87% 16.45% 8.81% 6.60%
EBIT Growth		 21.16% 2.82% 0.94% 11.85% 10.96% 1.48% 18.94% -3.20% 25.65% 11.36% 7.69%
NOPAT Growth		 17.32% 4.27% -2.67% 0.35% 21.17% 3.04% 15.26% -2.00% 73.36% -19.42% 6.54%
Net Income Growth		 24.79% 11.56% -2.51% 115.95% -45.87% 1.11% 19.84% -4.34% 78.62% -18.63% 7.56%
EPS Growth		 28.24% 17.43% 4.69% 8.21% 7.59% 0.64% 21.66% -1.57% 81.38% -16.42% 9.82%
Operating Cash Flow Growth		 20.45% 5.60% 3.85% -5.45% 26.03% 36.56% 18.82% -36.10% 10.63% 25.39% 32.08%
Free Cash Flow Firm Growth		 693.80% -30.87% -167.71% 165.08% -97.95% 17,755.38% 85.90% -10.62% -21.91% 56.61% 17.94%
Invested Capital Growth		 2.07% 7.07% 21.48% 9.34% 13.95% 2.98% -3.32% -1.81% 12.51% 0.26% -1.75%
Revenue Q/Q Growth		 1.86% 1.39% 1.96% 3.48% 3.09% 0.27% 3.12% 0.70% 0.99% 2.20% 1.41%
EBITDA Q/Q Growth		 -1.43% 3.47% -1.29% 5.61% 2.91% -1.30% 0.95% 1.47% 4.09% 2.65% 1.00%
EBIT Q/Q Growth		 -1.57% 4.06% -3.07% 7.22% 1.89% -2.83% 1.09% 4.36% 5.31% 3.16% 0.92%
NOPAT Q/Q Growth		 3.73% 5.32% -6.97% 9.39% 1.10% -0.33% -1.44% 3.84% 46.41% -22.25% 0.06%
Net Income Q/Q Growth		 8.44% 4.55% -3.67% 109.98% -47.78% -2.29% -0.51% 4.94% 46.92% -22.53% 0.21%
EPS Q/Q Growth		 9.00% 5.79% -2.19% 5.07% 0.65% -2.48% 0.00% 5.62% 46.98% -21.27% 0.64%
Operating Cash Flow Q/Q Growth		 -5.53% 11.59% -3.85% 13.86% -10.49% 14.17% 14.46% -3.73% -7.14% 1.88% 11.44%
Free Cash Flow Firm Q/Q Growth		 -25.81% 21.95% -93.99% -35.59% -99.18% 73.09% 78.96% 14.83% -6.70% 12.73% 10.54%
Invested Capital Q/Q Growth		 1.79% 0.80% 2.22% 4.88% 12.07% 6.89% -1.51% -3.05% 5.46% -2.00% -3.95%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 39.31% 39.54% 38.56% 35.96% 34.82% 34.81% 35.60% 35.15% 35.08% 35.45% 36.04%
EBITDA Margin		 17.89% 16.99% 16.58% 16.89% 16.29% 16.49% 17.52% 14.85% 16.89% 17.26% 17.26%
Operating Margin		 13.58% 13.27% 12.10% 11.60% 12.20% 11.83% 12.65% 11.49% 14.09% 14.73% 14.77%
EBIT Margin		 13.97% 13.75% 13.04% 13.30% 12.58% 12.12% 13.29% 11.84% 14.52% 15.19% 15.35%
Profit (Net Income) Margin		 9.74% 10.41% 9.53% 18.77% 8.66% 8.31% 9.19% 8.08% 14.10% 10.78% 10.88%
Tax Burden Percent		 79.47% 81.16% 81.36% 155.59% 76.33% 76.98% 76.47% 75.96% 104.82% 75.89% 75.67%
Interest Burden Percent		 87.76% 93.24% 89.83% 90.70% 90.18% 89.11% 90.38% 89.91% 92.63% 93.48% 93.64%
Effective Tax Rate		 20.53% 18.84% 18.64% 22.31% 23.67% 23.02% 23.53% 24.04% -4.82% 24.11% 24.33%
Return on Invested Capital (ROIC)		 16.31% 16.26% 13.82% 12.08% 13.10% 12.48% 14.42% 14.51% 23.88% 18.15% 19.48%
ROIC Less NNEP Spread (ROIC-NNEP)		 8.58% 13.95% 12.35% 47.67% 10.71% 9.36% 12.05% 10.85% 19.78% 15.04% 16.07%
Return on Net Nonoperating Assets (RNNOA)		 2.21% 4.35% 5.36% 27.69% 6.61% 5.01% 5.38% 4.48% 7.10% 4.00% 2.89%
Return on Equity (ROE)		 18.52% 20.62% 19.18% 39.77% 19.71% 17.50% 19.80% 18.98% 30.99% 22.15% 22.37%
Cash Return on Invested Capital (CROIC)		 14.27% 9.43% -5.58% 3.16% 0.06% 9.55% 17.80% 16.33% 12.11% 17.89% 21.25%
Operating Return on Assets (OROA)		 12.42% 12.45% 11.27% 11.44% 11.10% 9.64% 10.86% 10.82% 13.84% 14.79% 14.40%
Return on Assets (ROA)		 8.66% 9.42% 8.23% 16.14% 7.64% 6.61% 7.50% 7.39% 13.44% 10.49% 10.20%
Return on Common Equity (ROCE)		 18.52% 20.58% 19.11% 39.70% 19.71% 17.50% 19.80% 18.98% 30.99% 22.15% 22.37%
Return on Equity Simple (ROE_SIMPLE)		 18.39% 20.79% 18.32% 40.11% 18.05% 16.81% 19.47% 19.35% 28.08% 21.50% 0.00%
Net Operating Profit after Tax (NOPAT)		 266 277 270 270 328 338 389 381 661 533 568
NOPAT Margin		 10.79% 10.77% 9.85% 9.01% 9.31% 9.10% 9.68% 8.73% 14.77% 11.18% 11.17%
Net Nonoperating Expense Percent (NNEP)		 7.73% 2.32% 1.47% -35.59% 2.39% 3.12% 2.37% 3.65% 4.10% 3.11% 3.42%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 11.73% 18.81% 14.76% 13.87%
Cost of Revenue to Revenue		 60.69% 60.46% 61.44% 64.04% 65.18% 65.19% 64.40% 64.85% 64.92% 64.55% 63.96%
SG&A Expenses to Revenue		 24.71% 25.40% 25.19% 23.12% 22.58% 21.29% 21.52% 21.47% 20.40% 20.29% 20.61%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 25.73% 26.27% 26.46% 24.36% 22.62% 22.98% 22.95% 23.66% 20.99% 20.73% 21.28%
Earnings before Interest and Taxes (EBIT)		 344 354 357 399 443 449 535 517 650 724 780
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 440 437 454 507 573 612 705 649 756 823 877
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.75 3.50 4.00 3.43 4.49 4.09 5.08 4.51 2.76 3.17 3.16
Price to Tangible Book Value (P/TBV)		 29.25 32.57 0.00 0.00 0.00 0.00 0.00 157.57 12.11 10.93 11.50
Price to Revenue (P/Rev)		 1.99 1.75 2.08 1.61 2.16 2.02 2.40 1.88 1.38 1.59 1.59
Price to Earnings (P/E)		 20.42 16.70 21.65 8.54 24.90 24.31 26.10 23.29 9.81 14.75 14.60
Dividend Yield		 0.00% 0.00% 0.81% 1.18% 0.85% 0.99% 0.84% 1.11% 1.61% 1.42% 1.45%
Earnings Yield		 4.90% 5.99% 4.62% 11.71% 4.02% 4.11% 3.83% 4.29% 10.19% 6.78% 6.85%
Enterprise Value to Invested Capital (EV/IC)		 3.18 2.83 3.00 2.46 3.21 3.06 3.92 3.46 2.35 2.76 2.91
Enterprise Value to Revenue (EV/Rev)		 2.13 1.94 2.34 1.92 2.43 2.27 2.59 2.06 1.54 1.70 1.65
Enterprise Value to EBITDA (EV/EBITDA)		 11.90 11.40 14.13 11.35 14.94 13.75 14.75 13.88 9.10 9.88 9.58
Enterprise Value to EBIT (EV/EBIT)		 15.23 14.08 17.97 14.41 19.34 18.70 19.45 17.42 10.58 11.22 10.78
Enterprise Value to NOPAT (EV/NOPAT)		 19.72 17.98 23.79 21.27 26.14 24.89 26.71 23.63 10.40 15.25 14.80
Enterprise Value to Operating Cash Flow (EV/OCF)		 15.99 14.40 17.86 16.94 20.02 14.39 14.98 20.31 14.01 13.20 10.34
Enterprise Value to Free Cash Flow (EV/FCFF)		 22.54 31.00 0.00 81.30 5,919.40 32.53 21.65 20.99 20.52 15.47 13.57
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.61 0.70 0.85 0.93 0.85 0.87 0.87 0.78 0.56 0.51 0.61
Long-Term Debt to Equity		 0.57 0.54 0.70 0.69 0.79 0.71 0.67 0.68 0.37 0.50 0.46
Financial Leverage		 0.26 0.31 0.43 0.58 0.62 0.54 0.45 0.41 0.36 0.27 0.18
Leverage Ratio		 2.14 2.19 2.33 2.46 2.58 2.65 2.64 2.57 2.31 2.11 2.19
Compound Leverage Factor		 1.88 2.04 2.09 2.23 2.33 2.36 2.39 2.31 2.14 1.97 2.05
Debt to Total Capital		 37.96% 41.00% 45.98% 48.15% 46.08% 46.45% 46.61% 43.85% 36.04% 33.83% 37.69%
Short-Term Debt to Total Capital		 2.88% 9.10% 7.91% 12.13% 3.30% 8.28% 10.79% 5.45% 12.58% 0.72% 9.19%
Long-Term Debt to Total Capital		 35.07% 31.90% 38.06% 36.02% 42.77% 38.17% 35.81% 38.41% 23.46% 33.10% 28.50%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.21% 0.18% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 62.04% 58.79% 53.85% 51.85% 53.92% 53.55% 53.39% 56.15% 63.96% 66.17% 62.31%
Debt to EBITDA		 1.81 2.05 2.68 2.57 2.52 2.60 2.35 2.20 1.68 1.48 1.76
Net Debt to EBITDA		 0.77 1.08 1.57 1.84 1.70 1.49 1.07 1.20 0.90 0.67 0.39
Long-Term Debt to EBITDA		 1.68 1.60 2.22 1.92 2.34 2.14 1.81 1.92 1.09 1.45 1.33
Debt to NOPAT		 3.00 3.24 4.51 4.82 4.40 4.71 4.25 3.74 1.92 2.29 2.72
Net Debt to NOPAT		 1.28 1.70 2.64 3.46 2.98 2.70 1.94 2.04 1.03 1.03 0.60
Long-Term Debt to NOPAT		 2.78 2.52 3.73 3.61 4.09 3.87 3.27 3.27 1.25 2.24 2.05
Altman Z-Score		 3.72 3.37 3.18 2.89 3.14 2.89 3.40 3.53 3.29 3.80 3.33
Noncontrolling Interest Sharing Ratio		 0.00% 0.17% 0.34% 0.17% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.01 1.68 1.71 1.39 1.70 1.45 1.47 1.61 1.44 2.16 1.66
Quick Ratio		 1.75 1.42 1.43 1.17 1.52 1.30 1.37 1.49 1.29 1.94 1.53
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 232 161 -109 71 1.45 258 480 429 335 525 619
Operating Cash Flow to CapEx		 539.56% 424.89% 647.07% 402.69% 584.73% 839.97% 1,478.55% 877.62% 886.01% 768.02% 1,040.20%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.89 0.91 0.86 0.86 0.88 0.80 0.82 0.91 0.95 0.97 0.94
Accounts Receivable Turnover		 4.41 4.27 4.18 4.09 4.17 4.13 4.55 4.64 4.24 4.12 4.17
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 14.01 13.95 13.68 14.30 15.09 15.29 18.03 22.09 24.16 23.97 25.50
Accounts Payable Turnover		 116.55 156.58 135.50 66.69 71.08 134.75 133.20 93.26 91.47 95.85 101.52
Days Sales Outstanding (DSO)		 82.75 85.57 87.24 89.24 87.53 88.33 80.25 78.60 86.06 88.62 87.63
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 3.13 2.33 2.69 5.47 5.14 2.71 2.74 3.91 3.99 3.81 3.60
Cash Conversion Cycle (CCC)		 79.62 83.24 84.55 83.76 82.39 85.62 77.51 74.68 82.07 84.81 84.03
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,645 1,761 2,139 2,339 2,665 2,745 2,654 2,606 2,932 2,939 2,888
Invested Capital Turnover		 1.51 1.51 1.40 1.34 1.41 1.37 1.49 1.66 1.62 1.62 1.74
Increase / (Decrease) in Invested Capital		 33 116 378 200 326 79 -91 -48 326 7.76 -52
Enterprise Value (EV)		 5,237 4,978 6,412 5,752 8,566 8,406 10,398 9,012 6,878 8,125 8,404
Market Capitalization		 4,897 4,504 5,697 4,817 7,590 7,495 9,642 8,232 6,195 7,575 8,066
Book Value per Share		 $6.13 $6.41 $7.38 $7.39 $8.89 $9.69 $10.09 $9.96 $12.39 $13.55 $14.79
Tangible Book Value per Share		 $0.79 $0.69 ($0.23) ($0.88) ($0.61) ($0.52) ($0.02) $0.29 $2.82 $3.93 $4.07
Total Capital		 2,102 2,189 2,645 2,708 3,132 3,425 3,553 3,252 3,515 3,611 4,092
Total Debt		 798 897 1,216 1,304 1,443 1,591 1,656 1,426 1,267 1,221 1,542
Total Long-Term Debt		 737 698 1,007 976 1,340 1,307 1,272 1,249 825 1,195 1,166
Net Debt		 340 470 711 935 976 910 756 780 683 550 338
Capital Expenditures (CapEx)		 61 81 55 84 73 70 47 51 55 80 78
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 210 272 300 339 278 149 97 207 432 471 226
Debt-free Net Working Capital (DFNWC)		 661 695 804 707 745 830 996 853 1,016 1,143 1,430
Net Working Capital (NWC)		 601 496 595 379 641 546 613 676 574 1,116 1,054
Net Nonoperating Expense (NNE)		 26 9.38 8.70 -293 23 29 20 28 30 19 15
Net Nonoperating Obligations (NNO)		 340 470 711 935 976 910 756 780 683 550 338
Total Depreciation and Amortization (D&A)		 96 83 97 108 130 162 170 132 106 99 97
Debt-free, Cash-free Net Working Capital to Revenue		 8.55% 10.59% 10.96% 11.29% 7.89% 4.03% 2.41% 4.73% 9.65% 9.88% 4.45%
Debt-free Net Working Capital to Revenue		 26.87% 27.03% 29.39% 23.57% 21.16% 22.37% 24.77% 19.52% 22.69% 23.97% 28.15%
Net Working Capital to Revenue		 24.40% 19.28% 21.74% 12.62% 18.22% 14.73% 15.24% 15.47% 12.81% 23.42% 20.75%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.11 $1.30 $1.36 $1.48 $1.60 $1.62 $1.97 $1.92 $3.46 $2.88 $3.18
Adjusted Weighted Average Basic Shares Outstanding		 216.61M 206.86M 193.86M 190.67M 190.07M 190.40M 187.80M 184.18M 182.35M 178.39M 173.89M
Adjusted Diluted Earnings per Share		 $1.09 $1.28 $1.34 $1.45 $1.56 $1.57 $1.91 $1.88 $3.41 $2.85 $3.13
Adjusted Weighted Average Diluted Shares Outstanding		 219.15M 210.13M 197.05M 193.98M 195.16M 195.78M 192.96M 188.09M 185.14M 180.44M 176.65M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 210.55M 198.97M 193.48M 189.46M 190.40M 188.14M 185.17M 183.98M 180.73M 175.67M 169.86M
Normalized Net Operating Profit after Tax (NOPAT)		 266 277 270 270 328 338 389 381 442 533 568
Normalized NOPAT Margin		 10.79% 10.77% 9.85% 9.01% 9.31% 9.10% 9.68% 8.73% 9.86% 11.18% 11.17%
Pre Tax Income Margin		 12.26% 12.82% 11.71% 12.06% 11.35% 10.80% 12.01% 10.64% 13.45% 14.20% 14.37%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 17.90% 10.14% 21.21% 24.07% 21.78% 25.99% 15.84% 21.12% 21.31%
Augmented Payout Ratio		 94.70% 129.13% 102.16% 37.51% 31.06% 68.55% 102.50% 86.56% 51.57% 70.31% 21.31%

Quarterly Metrics And Ratios for Genpact

This table displays calculated financial ratios and metrics derived from Genpact's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 169,863,795.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 169,863,795.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.87
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 2.23% 3.96% 3.85% 6.39% 6.62% 8.94% 7.40% 6.65% 6.63% 5.65% 6.68%
EBITDA Growth		 16.74% 17.73% 8.94% 5.80% 9.63% 10.76% 8.95% 5.97% 7.78% 3.98% 9.01%
EBIT Growth		 25.05% 23.63% 12.50% 8.27% 11.72% 12.96% 12.04% 8.11% 7.59% 3.68% 10.14%
NOPAT Growth		 21.44% 221.35% 7.61% 5.14% 9.30% -50.58% 14.65% 5.35% 7.36% 0.18% 10.43%
Net Income Growth		 22.69% 224.72% 10.22% 4.94% 12.95% -51.28% 11.89% 8.79% 9.80% 0.83% 13.10%
EPS Growth		 25.49% 227.08% 12.28% 6.35% 15.63% -49.04% 14.06% 11.94% 12.16% 2.50% 17.81%
Operating Cash Flow Growth		 -28.53% -16.43% 24.96% 22.06% 41.44% 5.91% 258.19% -15.25% 34.97% 41.06% -158.20%
Free Cash Flow Firm Growth		 -69.61% -119.06% -199.80% -216.35% -345.14% 621.41% 183.88% 78.99% 271.20% 42.56% 20.89%
Invested Capital Growth		 3.43% 12.51% 10.35% 8.90% 7.90% 0.26% -0.24% 5.24% 0.24% -1.75% -0.75%
Revenue Q/Q Growth		 2.74% 0.92% -1.31% 3.98% 2.95% 3.12% -2.71% 3.25% 2.94% 2.17% -1.76%
EBITDA Q/Q Growth		 2.31% 1.93% -3.12% 4.71% 6.01% 2.98% -4.70% 1.85% 7.82% -0.65% -0.09%
EBIT Q/Q Growth		 3.48% 1.92% -2.79% 5.61% 6.77% 3.05% -3.58% 1.90% 6.26% -0.70% 2.43%
NOPAT Q/Q Growth		 3.42% 137.82% -60.00% 6.87% 7.51% 7.54% -7.21% -1.80% 9.56% 0.35% 2.28%
Net Income Q/Q Growth		 1.15% 147.73% -59.85% 4.31% 8.88% 6.85% -7.79% 1.42% 9.88% -1.88% 3.42%
EPS Q/Q Growth		 1.59% 145.31% -59.24% 4.69% 10.45% 8.11% -8.75% 2.74% 10.67% -1.20% 4.88%
Operating Cash Flow Q/Q Growth		 -5.79% 18.81% -113.32% 918.72% 9.17% -11.04% -80.11% 338.63% 73.86% -7.03% -108.21%
Free Cash Flow Firm Q/Q Growth		 -68.05% -180.27% -541.39% 29.27% 32.68% 270.73% 3.19% -117.71% 648.57% 42.17% -12.50%
Invested Capital Q/Q Growth		 -0.97% 5.46% 6.22% -1.83% -1.88% -2.00% 5.69% 3.56% -6.55% -3.95% 6.77%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 35.47% 35.56% 35.05% 35.40% 35.63% 35.70% 35.31% 35.88% 36.37% 36.56% 36.39%
EBITDA Margin		 17.06% 17.23% 16.91% 17.03% 17.54% 17.51% 17.16% 16.92% 17.73% 17.24% 17.53%
Operating Margin		 14.59% 14.20% 14.14% 14.47% 15.00% 15.23% 15.12% 14.30% 14.84% 14.82% 15.32%
EBIT Margin		 14.81% 14.95% 14.73% 14.96% 15.51% 15.50% 15.36% 15.16% 15.65% 15.21% 15.86%
Profit (Net Income) Margin		 10.35% 25.41% 10.34% 10.37% 10.97% 11.36% 10.77% 10.58% 11.29% 10.85% 11.42%
Tax Burden Percent		 75.91% 183.82% 74.79% 75.11% 75.69% 77.74% 74.68% 75.09% 77.02% 75.78% 76.29%
Interest Burden Percent		 92.12% 92.46% 93.85% 92.31% 93.41% 94.29% 93.87% 92.91% 93.68% 94.08% 94.36%
Effective Tax Rate		 24.09% -83.82% 25.21% 24.89% 24.31% 22.26% 25.32% 24.91% 22.98% 24.22% 23.71%
Return on Invested Capital (ROIC)		 17.96% 42.20% 16.10% 17.02% 18.33% 19.23% 17.61% 16.87% 19.07% 19.57% 19.49%
ROIC Less NNEP Spread (ROIC-NNEP)		 17.01% 41.13% 15.79% 16.28% 17.65% 18.26% 16.75% 16.58% 18.74% 18.44% 18.94%
Return on Net Nonoperating Assets (RNNOA)		 7.85% 14.77% 6.40% 6.08% 5.51% 4.86% 5.18% 4.55% 4.05% 3.32% 4.85%
Return on Equity (ROE)		 25.81% 56.96% 22.50% 23.09% 23.84% 24.08% 22.79% 21.42% 23.11% 22.89% 24.34%
Cash Return on Invested Capital (CROIC)		 13.14% 12.11% 12.69% 14.50% 16.12% 17.89% 17.93% 12.65% 18.65% 21.25% 19.55%
Operating Return on Assets (OROA)		 14.37% 14.25% 14.40% 14.21% 14.58% 15.09% 15.47% 14.26% 14.67% 14.27% 15.58%
Return on Assets (ROA)		 10.05% 24.22% 10.10% 9.85% 10.31% 11.06% 10.84% 9.95% 10.58% 10.17% 11.21%
Return on Common Equity (ROCE)		 25.81% 56.96% 22.50% 23.09% 23.84% 24.08% 22.79% 21.42% 23.11% 22.89% 24.34%
Return on Equity Simple (ROE_SIMPLE)		 21.38% 0.00% 27.94% 27.71% 27.69% 0.00% 21.51% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 126 299 120 128 137 148 137 135 148 148 151
NOPAT Margin		 11.07% 26.10% 10.58% 10.87% 11.35% 11.84% 11.29% 10.74% 11.43% 11.23% 11.69%
Net Nonoperating Expense Percent (NNEP)		 0.95% 1.07% 0.32% 0.74% 0.68% 0.96% 0.86% 0.30% 0.33% 1.13% 0.55%
Return On Investment Capital (ROIC_SIMPLE)		 - 8.51% - - - 4.09% 3.74% 3.47% 3.94% 3.62% 3.78%
Cost of Revenue to Revenue		 64.53% 64.44% 64.95% 64.60% 64.37% 64.30% 64.69% 64.12% 63.63% 63.44% 63.61%
SG&A Expenses to Revenue		 20.23% 20.71% 20.78% 20.37% 20.09% 19.95% 19.84% 21.24% 20.30% 21.01% 20.86%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 20.88% 21.36% 20.91% 20.93% 20.63% 20.47% 20.19% 21.58% 21.53% 21.74% 21.07%
Earnings before Interest and Taxes (EBIT)		 168 171 167 176 188 194 187 190 202 201 206
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 194 197 191 200 212 219 208 212 229 227 227
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.21 2.76 2.58 2.48 2.92 3.17 3.61 2.98 2.87 3.16 2.56
Price to Tangible Book Value (P/TBV)		 23.92 12.11 10.36 9.34 10.30 10.93 11.69 10.76 10.59 11.50 9.92
Price to Revenue (P/Rev)		 1.46 1.38 1.31 1.26 1.50 1.59 1.82 1.56 1.46 1.59 1.23
Price to Earnings (P/E)		 15.02 9.81 9.23 8.94 10.54 14.75 16.78 14.30 13.24 14.60 11.11
Dividend Yield		 1.51% 1.61% 1.72% 1.80% 1.52% 1.42% 1.25% 1.47% 1.58% 1.45% 1.87%
Earnings Yield		 6.66% 10.19% 10.83% 11.18% 9.49% 6.78% 5.96% 6.99% 7.55% 6.85% 9.00%
Enterprise Value to Invested Capital (EV/IC)		 2.60 2.35 2.17 2.13 2.53 2.76 3.06 2.59 2.58 2.91 2.25
Enterprise Value to Revenue (EV/Rev)		 1.63 1.54 1.49 1.42 1.63 1.70 1.96 1.69 1.55 1.65 1.34
Enterprise Value to EBITDA (EV/EBITDA)		 9.95 9.10 8.74 8.32 9.47 9.88 11.32 9.78 8.94 9.58 7.74
Enterprise Value to EBIT (EV/EBIT)		 11.70 10.58 10.09 9.55 10.82 11.22 12.77 10.98 10.05 10.78 8.68
Enterprise Value to NOPAT (EV/NOPAT)		 15.99 10.40 10.09 9.65 11.08 15.25 17.27 14.94 13.68 14.80 11.92
Enterprise Value to Operating Cash Flow (EV/OCF)		 13.67 14.01 13.51 12.13 12.57 13.20 13.95 12.82 10.64 10.34 9.26
Enterprise Value to Free Cash Flow (EV/FCFF)		 20.10 20.52 17.90 15.32 16.30 15.47 17.04 20.98 13.86 13.57 11.46
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.65 0.56 0.56 0.70 0.68 0.51 0.50 0.50 0.47 0.61 0.62
Long-Term Debt to Equity		 0.61 0.37 0.36 0.52 0.50 0.50 0.48 0.32 0.33 0.46 0.47
Financial Leverage		 0.46 0.36 0.41 0.37 0.31 0.27 0.31 0.27 0.22 0.18 0.26
Leverage Ratio		 2.44 2.31 2.19 2.26 2.25 2.11 2.03 2.13 2.16 2.19 2.13
Compound Leverage Factor		 2.25 2.13 2.05 2.09 2.10 1.99 1.90 1.98 2.03 2.06 2.01
Debt to Total Capital		 39.49% 36.04% 36.02% 41.13% 40.46% 33.83% 33.13% 33.35% 32.10% 37.69% 38.30%
Short-Term Debt to Total Capital		 2.44% 12.58% 13.24% 10.72% 10.59% 0.72% 0.71% 11.87% 10.03% 9.19% 9.38%
Long-Term Debt to Total Capital		 37.05% 23.46% 22.78% 30.41% 29.87% 33.10% 32.41% 21.47% 22.07% 28.50% 28.92%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 60.51% 63.96% 63.98% 58.87% 59.54% 66.17% 66.87% 66.65% 67.90% 62.31% 61.70%
Debt to EBITDA		 1.81 1.68 1.68 2.09 2.03 1.48 1.45 1.52 1.39 1.76 1.72
Net Debt to EBITDA		 1.06 0.90 1.06 0.92 0.75 0.67 0.78 0.74 0.53 0.39 0.68
Long-Term Debt to EBITDA		 1.69 1.09 1.06 1.54 1.50 1.45 1.42 0.98 0.95 1.33 1.30
Debt to NOPAT		 2.90 1.92 1.94 2.42 2.37 2.29 2.21 2.32 2.12 2.72 2.64
Net Debt to NOPAT		 1.71 1.03 1.22 1.07 0.88 1.03 1.19 1.13 0.81 0.60 1.05
Long-Term Debt to NOPAT		 2.72 1.25 1.22 1.79 1.75 2.24 2.16 1.50 1.46 2.05 1.99
Altman Z-Score		 3.08 2.96 3.03 2.79 2.99 3.45 3.94 3.27 3.14 3.00 2.82
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.91 1.44 1.54 1.89 1.85 2.16 2.45 1.53 1.51 1.66 1.69
Quick Ratio		 1.63 1.29 1.37 1.73 1.73 1.94 2.22 1.39 1.38 1.53 1.53
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 33 -27 -172 -122 -82 140 145 -26 140 200 175
Operating Cash Flow to CapEx		 1,215.11% 1,061.02% -106.48% 1,092.53% 1,156.14% 1,180.98% 183.98% 798.15% 1,890.04% 1,623.60% -98.35%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.97 0.95 0.98 0.95 0.94 0.97 1.01 0.94 0.94 0.94 0.98
Accounts Receivable Turnover		 4.33 4.24 4.20 4.23 4.11 4.12 4.15 4.06 4.02 4.17 4.21
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 24.62 24.16 24.23 24.20 24.09 23.97 23.98 23.53 25.81 25.50 26.37
Accounts Payable Turnover		 105.70 91.47 115.16 84.29 133.39 95.85 95.79 87.67 120.63 101.52 103.52
Days Sales Outstanding (DSO)		 84.34 86.06 86.94 86.19 88.76 88.62 88.01 89.84 90.90 87.63 86.71
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 3.45 3.99 3.17 4.33 2.74 3.81 3.81 4.16 3.03 3.60 3.53
Cash Conversion Cycle (CCC)		 80.89 82.07 83.77 81.86 86.02 84.81 84.20 85.68 87.87 84.03 83.18
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,780 2,932 3,114 3,057 3,000 2,939 3,107 3,217 3,007 2,888 3,083
Invested Capital Turnover		 1.62 1.62 1.52 1.57 1.61 1.62 1.56 1.57 1.67 1.74 1.67
Increase / (Decrease) in Invested Capital		 92 326 292 250 220 7.76 -7.36 160 7.13 -52 -23
Enterprise Value (EV)		 7,224 6,878 6,744 6,513 7,591 8,125 9,504 8,327 7,762 8,404 6,936
Market Capitalization		 6,453 6,195 5,928 5,794 6,986 7,575 8,850 7,696 7,300 8,066 6,327
Book Value per Share		 $11.08 $12.39 $12.72 $12.99 $13.44 $13.55 $13.96 $14.79 $14.60 $14.79 $14.57
Tangible Book Value per Share		 $1.49 $2.82 $3.17 $3.45 $3.81 $3.93 $4.31 $4.09 $3.96 $4.07 $3.75
Total Capital		 3,321 3,515 3,592 3,971 4,022 3,611 3,668 3,881 3,747 4,092 4,012
Total Debt		 1,312 1,267 1,294 1,634 1,628 1,221 1,215 1,294 1,203 1,542 1,536
Total Long-Term Debt		 1,230 825 818 1,208 1,201 1,195 1,189 833 827 1,166 1,160
Net Debt		 771 683 816 719 605 550 654 631 462 338 608
Capital Expenditures (CapEx)		 13 18 24 19 20 17 22 22 16 18 24
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 431 432 642 580 510 471 616 540 386 226 427
Debt-free Net Working Capital (DFNWC)		 972 1,016 1,121 1,494 1,532 1,143 1,177 1,203 1,127 1,430 1,355
Net Working Capital (NWC)		 891 574 645 1,068 1,106 1,116 1,151 743 751 1,054 979
Net Nonoperating Expense (NNE)		 8.19 7.83 2.71 5.88 4.66 5.93 6.33 2.00 1.76 5.02 3.50
Net Nonoperating Obligations (NNO)		 771 683 816 719 605 550 654 631 462 338 608
Total Depreciation and Amortization (D&A)		 26 26 25 24 24 25 22 22 27 27 22
Debt-free, Cash-free Net Working Capital to Revenue		 9.72% 9.65% 14.22% 12.64% 10.92% 9.88% 12.69% 10.96% 7.70% 4.45% 8.28%
Debt-free Net Working Capital to Revenue		 21.92% 22.69% 24.80% 32.56% 32.85% 23.97% 24.27% 24.41% 22.49% 28.15% 26.26%
Net Working Capital to Revenue		 20.09% 12.81% 14.27% 23.28% 23.71% 23.42% 23.73% 15.07% 14.99% 20.75% 18.97%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.65 $1.60 $0.65 $0.68 $0.75 $0.80 $0.75 $0.76 $0.84 $0.83 $0.87
Adjusted Weighted Average Basic Shares Outstanding		 181.40M 182.35M 180.42M 179.65M 177.60M 178.39M 175.53M 174.61M 173.58M 173.89M 170.31M
Adjusted Diluted Earnings per Share		 $0.64 $1.57 $0.64 $0.67 $0.74 $0.80 $0.73 $0.75 $0.83 $0.82 $0.86
Adjusted Weighted Average Diluted Shares Outstanding		 183.80M 185.14M 181.94M 180.91M 179.71M 180.44M 178.44M 177.05M 176.10M 176.65M 172.85M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 181.41M 180.73M 179.98M 178.18M 176.36M 175.67M 174.87M 174.27M 172.41M 169.86M 169.51M
Normalized Net Operating Profit after Tax (NOPAT)		 126 114 120 128 137 148 137 135 148 148 151
Normalized NOPAT Margin		 11.07% 9.94% 10.58% 10.87% 11.35% 11.84% 11.29% 10.74% 11.43% 11.23% 11.69%
Pre Tax Income Margin		 13.64% 13.83% 13.82% 13.81% 14.49% 14.62% 14.42% 14.09% 14.66% 14.31% 14.97%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 22.84% 15.84% 15.92% 16.14% 16.07% 21.12% 20.99% 21.00% 20.93% 21.31% 21.02%
Augmented Payout Ratio		 22.84% 51.57% 15.92% 16.14% 16.07% 70.31% 20.99% 21.00% 20.93% 21.31% 21.02%

Financials Breakdown Chart

Key Financial Trends

Genpact’s recent results show steady revenue growth and solid profitability, but cash flow has become more uneven in early 2026. Over the last four years, the company has generally grown sales and earnings while keeping margins fairly stable, yet the latest quarter raised a caution flag because operating cash flow turned negative despite continued net income.

Top takeaways for investors:

  • Revenue has trended higher year over year, with Q1 2026 operating revenue at $1.30 billion versus $1.21 billion in Q1 2025 and $1.09 billion in Q1 2023.
  • Net income remained resilient in Q1 2026 at $148.0 million, only slightly above Q1 2025’s $130.9 million and well above Q1 2023’s $106.1 million.
  • Gross profit improved meaningfully over the long run, rising to $471.7 million in Q1 2026 from $397.5 million in Q1 2024 and $370.2 million in Q1 2023.
  • The company has consistently generated quarterly earnings, with diluted EPS of $0.86 in Q1 2026 versus $0.73 in Q1 2025 and $0.57 in Q1 2023.
  • Balance sheet equity has grown over time, with total common equity up to $2.48 billion in Q1 2026 from $2.30 billion in Q1 2024 and $1.93 billion in Q2 2023.
  • Cash and equivalents remain healthy at $578.1 million in Q1 2026, supported by an additional $350 million in short-term investments.
  • Genpact still produced positive operating cash flow in most prior quarters, including $286.7 million in Q4 2025 and $308.4 million in Q3 2025.
  • Share count has been relatively stable, though dilution remains modestly higher than basic shares due to employee equity and compensation-related issuance.
  • The company continues to pay dividends, but the payout is relatively small compared with earnings and cash generation.
  • Q1 2026 operating cash flow was negative $23.5 million, a sharp deterioration from positive operating cash flow in the prior several quarters.
  • Long-term debt jumped to $1.16 billion in Q1 2026 from $827.0 million in Q3 2025, reflecting a sizable increase in leverage.
  • Total liabilities rose to $3.14 billion in Q1 2026 from $2.82 billion in Q3 2025, which narrows balance sheet flexibility.
  • Goodwill remains large at $1.77 billion, so a significant portion of assets is tied to acquisitions rather than hard assets.
  • Other operating liabilities are substantial, and the company’s cash generation now looks more sensitive to working-capital swings.

Revenue and earnings trend: Genpact has delivered a fairly consistent growth pattern. Quarterly revenue moved from $1.09 billion in Q1 2023 to $1.30 billion in Q1 2026, showing gradual expansion rather than rapid acceleration. Profitability has also held up well: net income climbed from $106.1 million in Q1 2023 to $148.0 million in Q1 2026, while EPS improved despite a fairly stable share count.

Margins and operating efficiency: Gross margin has remained respectable, and operating income has generally stayed near the $180 million to $200 million range in recent quarters. However, Q1 2026 operating income of $198.6 million was only modestly above Q1 2025 levels, suggesting that revenue growth is being offset by higher costs and expenses. That means investors may want to watch whether management can turn sales growth into stronger incremental profit.

Cash flow is the biggest near-term concern: The latest quarter showed a clear mismatch between accounting earnings and cash generation. Net income was healthy, but changes in working capital pushed operating cash flow below zero. That is a red flag if it continues, because free cash flow is what ultimately supports dividends, buybacks, debt reduction, and acquisitions.

Balance sheet and capital structure: Genpact’s balance sheet is still manageable, with over $900 million of combined cash and short-term investments in Q1 2026. But debt increased meaningfully in the last several quarters, and liabilities have moved higher. The company is not under obvious distress, yet the rise in leverage makes consistent cash generation more important.

Bottom line: Genpact still looks like a profitable, established business with gradual top-line growth and decent earnings power. The key issue to monitor is whether Q1 2026’s negative operating cash flow was a one-quarter working-capital issue or the start of a softer cash conversion trend. If cash flow rebounds, the current results would look constructive; if not, the company may face more pressure despite stable earnings.

06/16/26 02:04 PM ETAI Generated. May Contain Errors.

Genpact Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Genpact's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Genpact's net income appears to be on an upward trend, with a most recent value of $552.49 million in 2025, rising from $239.82 million in 2015. The previous period was $513.67 million in 2024. Find out what analysts predict for Genpact in the coming months.

Genpact's total operating income in 2025 was $750.21 million, based on the following breakdown:
  • Total Gross Profit: $1.83 billion
  • Total Operating Expenses: $1.08 billion

Over the last 10 years, Genpact's total revenue changed from $2.46 billion in 2015 to $5.08 billion in 2025, a change of 106.4%.

Genpact's total liabilities were at $3.29 billion at the end of 2025, a 26.8% increase from 2024, and a 121.2% increase since 2015.

In the past 10 years, Genpact's cash and equivalents has ranged from $368.40 million in 2018 to $899.46 million in 2021, and is currently $853.84 million as of their latest financial filing in 2025.

Over the last 10 years, Genpact's book value per share changed from 6.13 in 2015 to 14.79 in 2025, a change of 141.1%.


Related Companies

Financial statements for NYSE:G last updated on 5/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
This Could Be the Biggest Monetary Shift in 50 Years
Tucked inside U.S. Code Title 31, Section 5117 is a provision allowing the Treasury to reprice America's gold ...
Americas Gold Company | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
How to play the Biggest IPO in stock market history!
SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...
InvestPub | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
J.P. Morgan is betting on this coin
It feels like the world just changed overnight. Middle East peace talks are advancing. Geopolitical risk is ev...
Crypto 101 Media | Sponsoredtc pixel